FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3162313488> ?p ?o ?g. }

• W3162313488 endingPage "914" @default.
• W3162313488 startingPage "914" @default.
• W3162313488 abstract "In foot-and-mouth disease (FMD)-endemic countries, vaccination is commonly used to control the disease, whilst in FMD-free countries, vaccination is considered as an option, in addition to culling the infected and in contact animals. FMD vaccines are mainly comprised of inactivated virions and stimulate protective antibodies to virus structural proteins. In contrast, infection with FMD virus leads to virus replication and additional antibody responses to viral nonstructural proteins (NSP). Therefore, antibodies against NSPs are used to differentiate infection in vaccinated animals (DIVA), in order to estimate the prevalence of infection or its absence. Another advantage of NSP antibody tests is that they detect FMD infection in the field, irrespective of the serotypes of virus in circulation. In cattle, the NSP tests that target the 3ABC polyprotein provides the highest sensitivity, detecting up to 90% of vaccinated animals that become carriers after exposure to infection, with a specificity of around 99%. Due to insufficient diagnostic sensitivity and specificity, detection of a low level of infection is difficult at the population level with a high degree of confidence. The low level of non-specific responses can be overcome by retesting samples scored positive using a second confirmatory test, which should have at least comparable sensitivity to the first test. In this study, six in-house tests were developed incorporating different NSP antigens, and validated using bovine sera from naïve animals, field cases and experimentally vaccinated and/or infected animals. In addition, two (short and long incubation) new commercial NSP tests based on 3ABC competitive blocking ELISAs (ID Screen® FMD NSP Competition, IDvet, France) were validated in this study. The two commercial ELISAs had very similar sensitivities and specificities that were not improved by lengthening the incubation period. Several of the new in-house tests had performance characteristics that were nearly as good as the commercial ELISAs. Finally, the in-house tests were evaluated for use as confirmatory tests following screening with the PrioCHECK® and ID Screen® FMDV NS commercial kits, to assess the diagnostic performance produced by a multiple testing strategy. The in-house tests could be used in series (to confirm) or in parallel (to augment) with the PrioCHECK® and IDvet® FMDV NS commercial kits, in order to improve either the specificity or sensitivity of the overall test system, although this comes at the cost of a reduction in the counterpart (sensitivity/specificity) parameter." @default.
• W3162313488 created "2021-05-24" @default.
• W3162313488 creator A5006783107 @default.
• W3162313488 creator A5012559765 @default.
• W3162313488 creator A5013747084 @default.
• W3162313488 creator A5031027914 @default.
• W3162313488 creator A5066786419 @default.
• W3162313488 creator A5069965708 @default.
• W3162313488 creator A5090282714 @default.
• W3162313488 creator A5090681633 @default.
• W3162313488 date "2021-05-15" @default.
• W3162313488 modified "2023-10-10" @default.
• W3162313488 title "Development and Validation of Confirmatory Foot-and-Mouth Disease Virus Antibody ELISAs to Identify Infected Animals in Vaccinated Populations" @default.
• W3162313488 cites W169573040 @default.
• W3162313488 cites W1946946176 @default.
• W3162313488 cites W1963539940 @default.
• W3162313488 cites W1964390348 @default.
• W3162313488 cites W1970491106 @default.
• W3162313488 cites W1977633146 @default.
• W3162313488 cites W1982166242 @default.
• W3162313488 cites W1990215018 @default.
• W3162313488 cites W1994068092 @default.
• W3162313488 cites W1997534896 @default.
• W3162313488 cites W2004072334 @default.
• W3162313488 cites W2016005911 @default.
• W3162313488 cites W2017131215 @default.
• W3162313488 cites W2021014107 @default.
• W3162313488 cites W2028151883 @default.
• W3162313488 cites W2030000595 @default.
• W3162313488 cites W2040088849 @default.
• W3162313488 cites W2043771648 @default.
• W3162313488 cites W2045049507 @default.
• W3162313488 cites W2050583820 @default.
• W3162313488 cites W2065975543 @default.
• W3162313488 cites W2068225985 @default.
• W3162313488 cites W2075643158 @default.
• W3162313488 cites W2075918933 @default.
• W3162313488 cites W2076061140 @default.
• W3162313488 cites W2077157056 @default.
• W3162313488 cites W2089599256 @default.
• W3162313488 cites W2102386709 @default.
• W3162313488 cites W2111677449 @default.
• W3162313488 cites W2112651984 @default.
• W3162313488 cites W2128151337 @default.
• W3162313488 cites W2131848323 @default.
• W3162313488 cites W2134012062 @default.
• W3162313488 cites W2138524557 @default.
• W3162313488 cites W2139845693 @default.
• W3162313488 cites W2148319062 @default.
• W3162313488 cites W2163410014 @default.
• W3162313488 cites W2166552539 @default.
• W3162313488 cites W2328176404 @default.
• W3162313488 doi "https://doi.org/10.3390/v13050914" @default.
• W3162313488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8156621" @default.
• W3162313488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34063385" @default.
• W3162313488 hasPublicationYear "2021" @default.
• W3162313488 type Work @default.
• W3162313488 sameAs 3162313488 @default.
• W3162313488 citedByCount "1" @default.
• W3162313488 countsByYear W31623134882023 @default.
• W3162313488 crossrefType "journal-article" @default.
• W3162313488 hasAuthorship W3162313488A5006783107 @default.
• W3162313488 hasAuthorship W3162313488A5012559765 @default.
• W3162313488 hasAuthorship W3162313488A5013747084 @default.
• W3162313488 hasAuthorship W3162313488A5031027914 @default.
• W3162313488 hasAuthorship W3162313488A5066786419 @default.
• W3162313488 hasAuthorship W3162313488A5069965708 @default.
• W3162313488 hasAuthorship W3162313488A5090282714 @default.
• W3162313488 hasAuthorship W3162313488A5090681633 @default.
• W3162313488 hasBestOaLocation W31623134881 @default.
• W3162313488 hasConcept C10389963 @default.
• W3162313488 hasConcept C126322002 @default.
• W3162313488 hasConcept C147483822 @default.
• W3162313488 hasConcept C159047783 @default.
• W3162313488 hasConcept C159654299 @default.
• W3162313488 hasConcept C194775826 @default.
• W3162313488 hasConcept C203014093 @default.
• W3162313488 hasConcept C22070199 @default.
• W3162313488 hasConcept C2522874641 @default.
• W3162313488 hasConcept C2776151397 @default.
• W3162313488 hasConcept C2779070877 @default.
• W3162313488 hasConcept C2779134260 @default.
• W3162313488 hasConcept C2781092335 @default.
• W3162313488 hasConcept C2908647359 @default.
• W3162313488 hasConcept C42972112 @default.
• W3162313488 hasConcept C52991690 @default.
• W3162313488 hasConcept C71924100 @default.
• W3162313488 hasConcept C86803240 @default.
• W3162313488 hasConcept C99454951 @default.
• W3162313488 hasConceptScore W3162313488C10389963 @default.
• W3162313488 hasConceptScore W3162313488C126322002 @default.
• W3162313488 hasConceptScore W3162313488C147483822 @default.
• W3162313488 hasConceptScore W3162313488C159047783 @default.
• W3162313488 hasConceptScore W3162313488C159654299 @default.
• W3162313488 hasConceptScore W3162313488C194775826 @default.
• W3162313488 hasConceptScore W3162313488C203014093 @default.
• W3162313488 hasConceptScore W3162313488C22070199 @default.
• W3162313488 hasConceptScore W3162313488C2522874641 @default.

• next